ResMed is Friday's top mover after gaining 6.95%
Leading equity indices in the US rose as Dow Jones gained 0.8% and closed at 34,100. S&P 500 ended the session at 4,169.48 after a 0.83% gain.
“Top Movers” are assets that recorded the highest percentage change compared to their nearest peers. Friday's most active healthcare stocks are listed below.
ResMed ended Friday at $240.96, a 6.95% increase
It was more of the same for ResMed Friday — the medical device developer topped out at $243.52 having ended Friday at $240.96. However, despite early momentum, the stock gave up its gains to now trade at $240.96. ResMed's market cap is currently $35.40 billion with an average daily trading volume of 483,571 shares. So far this year, it has been outperforming the S&P 500 by 8.11%.
Catalent levels up 6.75% in Friday's session; traders eye opening bell in a day time
Friday's session pointed in the same direction — the pharmaceutical developer rallied 6.75% and maintained $50.12. The company is currently trading with a market cap of $9 billion with an average daily volume of 4.70 million shares. So far this year, it has performed better than the S&P 500 by 2.7%.
Catalent is scheduled to announce earnings results tomorrow. The consensus EPS estimate is 0.53 and the consensus revenue estimate is $1 billion.
UroGen Pharma ended the session at $11.59 (-7%)
The urothelial and specialty cancer treatment company has recovered almost all of its session losses after dipping down to $10.28 Friday. The biotechnology company's market cap currently stands at $271.68 million with an average daily volume of 181,213 shares.